@turilrh @ESC_Journals Yes, a significant increase in amputation with canagliflozin in CANVAS. While some degree of caution would be prudent, we did not see that in an experimental model in @JACCJournals: https://t.co/0lZQhTtZj9 or in an observational anal
RT @DLBHATTMD: @cpcannon You might find this interesting - the results ran contrary to our hypothesis: https://t.co/ogTxktTSlt #cardiotwitt…
@cpcannon You might find this interesting - the results ran contrary to our hypothesis: https://t.co/ogTxktTSlt #cardiotwitter #cardiology #diabetes
RT @drleonjimenez: Canagliflozin Improves the Recovery of Blood Flow in an Experimental M... https://t.co/KWP9VKyW83 ESTE ARTICULO REBATE L…
RT @drleonjimenez: Canagliflozin Improves the Recovery of Blood Flow in an Experimental M... https://t.co/KWP9VKyW83 ESTE ARTICULO REBATE L…
RT @drleonjimenez: Canagliflozin Improves the Recovery of Blood Flow in an Experimental M... https://t.co/KWP9VKyW83 ESTE ARTICULO REBATE L…
RT @drleonjimenez: Canagliflozin Improves the Recovery of Blood Flow in an Experimental M... https://t.co/KWP9VKyW83 ESTE ARTICULO REBATE L…
Canagliflozin Improves the Recovery of Blood Flow in an Experimental M... https://t.co/KWP9VKyW83 ESTE ARTICULO REBATE LA TEORIA DE LA HEMOCONCENTRACION...
Canagliflozin Improves the Recovery of Blood Flow in an Experimental Model of Severe Limb Ischemia https://t.co/TzsG5XFB7p
nuevo capítulo sobre la canaglifozina - riesgo de amputación - enfermedad arterial periférica ... continuará ... https://t.co/t4xO9BndNO
In a murine model: “the results suggest that the increased risk of amputation reported with canagliflozin in the clinical setting may not be related to changes in limb blood flow induced by hemoconcentration” https://t.co/EB7PwVXCCs
RT @JACCJournals: Canagliflozin and amputation risk – is there a link? https://t.co/z0NYAggg7d #JACCBTS #openaccess #research @StMikesHospi…
RT @JACCJournals: Canagliflozin and amputation risk – is there a link? https://t.co/z0NYAggg7d #JACCBTS #openaccess #research @StMikesHospi…
RT @JACCJournals: Canagliflozin and amputation risk – is there a link? https://t.co/z0NYAggg7d #JACCBTS #openaccess #research @StMikesHospi…
RT @JACCJournals: Canagliflozin and amputation risk – is there a link? https://t.co/z0NYAggg7d #JACCBTS #openaccess #research @StMikesHospi…
RT @JACCJournals: Canagliflozin and amputation risk – is there a link? https://t.co/z0NYAggg7d #JACCBTS #openaccess #research @StMikesHospi…
RT @JACCJournals: Canagliflozin and amputation risk – is there a link? https://t.co/z0NYAggg7d #JACCBTS #openaccess #research @StMikesHospi…
RT @JACCJournals: Canagliflozin and amputation risk – is there a link? https://t.co/z0NYAggg7d #JACCBTS #openaccess #research @StMikesHospi…
RT @JACCJournals: Canagliflozin and amputation risk – is there a link? https://t.co/z0NYAggg7d #JACCBTS #openaccess #research @StMikesHospi…
RT @JACCJournals: Canagliflozin and amputation risk – is there a link? https://t.co/z0NYAggg7d #JACCBTS #openaccess #research @StMikesHospi…
Canagliflozin and amputation risk – is there a link? https://t.co/z0NYAggg7d #JACCBTS #openaccess #research @StMikesHospital https://t.co/e8gccnTySC